Mobidiag finds multiple international distributors
Finnish diagnostics company Mobidiag has inked several exclusive distribution agreements for its Amplidiag and Novodiag products in Europe and the Middle East.
Mobidiag signed an exclusive agreement with Helix2 for the distribution of the Amplidiag and Novodiag diagnostics solutions in Greece, and another with Interlab INTERAUTOMATIKA for distribution in Latvia and Lithuania.
The Finnish molecular diagnostics company also secured its first agreement in the Middle East, with Ibn Rushd Medical & Scientific Equipment set to distribute Novodiag in Kuwait. All the agreements are effective immediately and will initially cover a period of two years.
“We are delighted to have extended our commercial footprint into new international territories including our first agreement in the Middle East,” said Tuomas Tenkanen, CEO of Mobidiag. “Mobidiag continues to see demand grow for the Amplidiag and Novodiag solutions and we are in discussions with several distribution partners in a range of international markets, as customers look for comprehensive diagnostic solutions to a wide range of infectious diseases in both centralised and decentralised laboratories.”
Mobidiag recently also entered the Chinese market together with Autobio Diagnostics and, earlier in 2018, secured additional funding towards its global ambitions.